国际妇产科学杂志

国际妇产科学杂志 ›› 2015, Vol. 42 ›› Issue (3): 288-290.

• 论著 • 上一篇    下一篇

外阴鳞癌59例临床分析

何英慧，温馨，许言，郑香梅，韩雪，李博，欧阳玲   

  1. 110004 沈阳，中国医科大学附属盛京医院妇产科[何英慧（现工作于锦州市妇婴医院），温馨，许言，郑香梅，韩雪，李博，欧阳玲]
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2015-06-15 发布日期:2015-06-15
  • 通讯作者: 欧阳玲

Clinical Analysis of 59 Cases Vulvar Squamous Cell Carcinomas

HE Ying-hui，WEN Xin，XU Yan，ZHENG Xiang-mei，HAN Xue，LI Bo，OUYANG Ling   

  1. Department of Obstetrics and Gynecology，Shengjing Hospital of China Medical University，Shenyang 110004，China[HE Ying-hui（now Working at Women and Children′s Hospital of Jinzhou），WEN Xin，XU Yan，ZHENG Xiang-mei，HAN Xue，LI Bo，OUYANG Ling]
  • Received:1900-01-01 Revised:1900-01-01 Published:2015-06-15 Online:2015-06-15
  • Contact: OUYANG Ling

PDF (PC)

6004

摘要： 目的：探讨外阴鳞癌的临床特征、手术方式的选择及预后情况。方法：对2006年2月—2012年10月在中国医科大学附属盛京医院进行手术治疗的59例外阴鳞癌患者进行回顾性分析。结果：59例患者中，不同病理分期和临床分期患者的生存率差异有统计学意义，ⅠA期患者预后最好；不同年龄组中，发病年龄＜45岁者预后最差；不同手术方式在随访患者中生存率差异有统计学意义。结论：外阴鳞癌的预后与发病年龄、肿瘤的部位、肿瘤的浸润深度及大小、病理类型、手术方式、术前术后是否辅助放化疗等多种因素有关，治疗应个体化。

关键词: 外阴肿瘤, 肿瘤, 鳞状细胞, 预后

Abstract: Objective： To study the clinical features，selection of operation methods and prognosis of vulvar squamous cell carcinomas. Methods：59 patients with vulvar squamous carcinoma for surgical treatment from February 2006 to October 2012 in Shengjing Hospital Affiliated to China Medical University were retrospectively analyzed. Results：59 patients of survival difference with different pathological stages and clinical stages was statistically significant difference，ⅠA best prognosis in patients with; In different ages，the worst prognosis was the onset age less than 45. Different ways of operation in patients with follow-up survival rate difference was statistically significant. Conclusions：The prognosis of vulvar squamous cell carcinomas were relate age，tumor site，tumor infiltration depth and size，pathological type，operation method and postoperative adjuvant radiation and chemotherapy，and individualized treatment should be considered.

Key words: Vulvar neoplasms, Neoplasms, squamous cell, Prognosis